EP1765365A4 - Compositions et procedes pour la codelivrance de medicaments anticancereux, de medicaments anti-angiogeniques, et d'un polysaccharide - Google Patents

Compositions et procedes pour la codelivrance de medicaments anticancereux, de medicaments anti-angiogeniques, et d'un polysaccharide

Info

Publication number: EP1765365A4
Authority: EP; European Patent Office
Prior art keywords: drugs; ofr; polysaccharide; delivery; compositions
Prior art date: 2004-06-22
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP05786102A

Other languages

German (de)

English (en)

Other versions

EP1765365A2 (fr

Inventor

David Platt

Eliezer Zomer

Anatole Klyosov

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Pro Pharmaceuticals Inc

Original Assignee

Pro Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-06-22

Filing date

2005-06-21

Publication date

2008-02-20

2005-06-21 Application filed by Pro Pharmaceuticals Inc filed Critical Pro Pharmaceuticals Inc

2007-03-28 Publication of EP1765365A2 publication Critical patent/EP1765365A2/fr

2008-02-20 Publication of EP1765365A4 publication Critical patent/EP1765365A4/fr

Status Withdrawn legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Gastroenterology & Hepatology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Inorganic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
Oncology (AREA)
Molecular Biology (AREA)
Hematology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)

EP05786102A 2004-06-22 2005-06-21 Compositions et procedes pour la codelivrance de medicaments anticancereux, de medicaments anti-angiogeniques, et d'un polysaccharide Withdrawn EP1765365A4 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US58195804P	2004-06-22	2004-06-22
PCT/US2005/021827 WO2006002106A2 (fr)	2004-06-22	2005-06-21	Compositions et procedes pour la codelivrance de medicaments anticancereux, de medicaments anti-angiogeniques, et d'un polysaccharide

Publications (2)

Publication Number	Publication Date
EP1765365A2 EP1765365A2 (fr)	2007-03-28
EP1765365A4 true EP1765365A4 (fr)	2008-02-20

Family

ID=35782284

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP05786102A Withdrawn EP1765365A4 (fr)	2004-06-22	2005-06-21	Compositions et procedes pour la codelivrance de medicaments anticancereux, de medicaments anti-angiogeniques, et d'un polysaccharide

Country Status (6)

Country	Link
EP (1)	EP1765365A4 (fr)
JP (1)	JP2008503583A (fr)
CN (1)	CN101267828A (fr)
BR (1)	BRPI0512394A (fr)
CA (1)	CA2570570A1 (fr)
WO (1)	WO2006002106A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BRPI0911960B1 (pt)	2008-05-14	2022-03-22	Agriculture Victoria Services Pty Limited	Uso de angiogenina no preparo de uma composição, suplemento alimentar ou nutracêutico para promover o crescimento e melhora muscular
AU2013204721B2 (en) *	2008-05-14	2016-08-18	Agriculture Victoria Services Pty Ltd	Methods for treating cachexia
CZ302789B6 (cs)	2009-11-25	2011-11-09	Zentiva, K. S.	Zpusob zvýšení rozpustnosti farmaceuticky aktivních látek a cílený (kontrolovaný) transport do streva
AU2013204740C1 (en) *	2012-05-10	2015-10-01	Agriculture Victoria Services Pty Ltd	Methods of treating cancer using angiogenin or an angiogenin agonist
FR3022462B1 (fr) *	2014-06-18	2018-04-27	Laboratoire Francais Du Fractionnement Et Des Biotechnologies	Composition orale d'anticorps anti-tnfalpha

Citations (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5773425A (en) *	1982-05-07	1998-06-30	Carrington Laboratories, Inc.	Antineoplastic uses of aloe products
US5811410A (en) *	1989-09-21	1998-09-22	Hyal Pharmaceutical Corporation	Method of administering of a hyaluronic acid and an NSAID to decrease side effects of the NSAID
EP0958825A1 (fr) *	1998-05-18	1999-11-24	Tiense Suikerraffinaderij N.V. (Raffinerie Tirlemontoise S.A.)	Composition synergique à activité anticancéreuse à base de carbohydrates non digestibles et d'un médicament anti-cancéreux
WO2001017377A1 (fr) *	1999-09-06	2001-03-15	Beisel Guenther	Substance reticulee servant a produire un effet rassasiant durable et procede de production correspondant
WO2002076474A1 (fr) *	2001-03-27	2002-10-03	Pro-Pharmaceuticals, Inc.	Co-administration d'un polysaccharide avec un agent chimiotherapeutique permettant le traitement du cancer
KR20040045795A (ko) *	2002-11-25	2004-06-02	주식회사한국신약	펠리누스 린테우스에서 추출한 다당류와 마이토마이신ｃ를 포함하는 복합 항암제

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20020107222A1 (en) *	1993-03-01	2002-08-08	David Platt	Modified polysaccharides for treatment of cancer
US5834442A (en) *	1994-07-07	1998-11-10	Barbara Ann Karmanos Cancer Institute	Method for inhibiting cancer metastasis by oral administration of soluble modified citrus pectin

2005
- 2005-06-21 EP EP05786102A patent/EP1765365A4/fr not_active Withdrawn
- 2005-06-21 CA CA002570570A patent/CA2570570A1/fr not_active Abandoned
- 2005-06-21 BR BRPI0512394-1A patent/BRPI0512394A/pt not_active IP Right Cessation
- 2005-06-21 WO PCT/US2005/021827 patent/WO2006002106A2/fr not_active Ceased
- 2005-06-21 CN CNA2005800207078A patent/CN101267828A/zh active Pending
- 2005-06-21 JP JP2007518186A patent/JP2008503583A/ja active Pending

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5773425A (en) *	1982-05-07	1998-06-30	Carrington Laboratories, Inc.	Antineoplastic uses of aloe products
US5811410A (en) *	1989-09-21	1998-09-22	Hyal Pharmaceutical Corporation	Method of administering of a hyaluronic acid and an NSAID to decrease side effects of the NSAID
EP0958825A1 (fr) *	1998-05-18	1999-11-24	Tiense Suikerraffinaderij N.V. (Raffinerie Tirlemontoise S.A.)	Composition synergique à activité anticancéreuse à base de carbohydrates non digestibles et d'un médicament anti-cancéreux
WO2001017377A1 (fr) *	1999-09-06	2001-03-15	Beisel Guenther	Substance reticulee servant a produire un effet rassasiant durable et procede de production correspondant
WO2002076474A1 (fr) *	2001-03-27	2002-10-03	Pro-Pharmaceuticals, Inc.	Co-administration d'un polysaccharide avec un agent chimiotherapeutique permettant le traitement du cancer
KR20040045795A (ko) *	2002-11-25	2004-06-02	주식회사한국신약	펠리누스 린테우스에서 추출한 다당류와 마이토마이신ｃ를 포함하는 복합 항암제

Also Published As

Publication number	Publication date
WO2006002106A2 (fr)	2006-01-05
CN101267828A (zh)	2008-09-17
JP2008503583A (ja)	2008-02-07
BRPI0512394A (pt)	2008-03-11
EP1765365A2 (fr)	2007-03-28
WO2006002106A3 (fr)	2006-10-19
CA2570570A1 (fr)	2006-01-05

Publication	Publication Date	Title
IL181734A (en)	2015-10-29	Surapnib Tosylate Polymorph, Pharmaceuticals Containing It and Using It to Make Medicines
IL203915A (en)	2016-04-21	Annotations of 2-Benzylphenyl-6-Hydroxymethyl-Tetrahydro-2 H-Pyrene-3,4,5-Triol
IL194699A (en)	2014-07-31	Tetrahydropridridines, preparations containing them and uses in the preparation of drugs
EP1909780A4 (fr)	2012-03-07	Medicaments antituberculeux: compositions et methodes
IL195488A (en)	2017-04-30	Compounds, pharmaceuticals containing them and their uses
IL194707A (en)	2015-10-29	Anti-cancer synergistic combination of Texans and 13-Dioxanthracyclines and a pharmacological preparation containing this combination
IL190292A (en)	2017-01-31	History of pyridopyrimidinone and their pharmaceutical preparations
IL184065A (en)	2015-09-24	Tetrahydroquinoline analogs, their use in the preparation of pharmaceuticals and pharmaceutical compositions containing them
IL242883B (en)	2022-01-01	Aryl-amino and heteroaryl-amino converted deoxazolines and pharmaceutical preparations containing them
EP1962906A4 (fr)	2009-11-18	Composition pharmaceutique comprenant au moins un compose contre le cancer et au moins un polymere
IL181301A0 (en)	2007-07-04	Cyclopamine analogues, pharmaceutical compositions comprising them and uses thereof
IL231576A (en)	2015-09-24	Derivatives of adamantyl-acetamide, the pharmaceutical compositions containing them and their use in the preparation of medicines
EP1857489A4 (fr)	2010-06-23	Microparticule et composition pharmaceutique
EP2056835A4 (fr)	2013-01-30	Compositions pharmaceutiques et leurs utilisations
IL206952A (en)	2014-09-30	History of Aminodia Hydrothiazine, medicinal preparations containing them, and their use in the preparation of medicines
IL221323A0 (en)	2012-09-24	1-methyl-1h- pyridin-2-one- phenanthridine derivatives and pharmaceutical compositions containing the same
IL193164A0 (en)	2009-08-03	Polymeric conjugates of 7-ethyl-10-hydroxycamptothecin and pharmaceutical compositions containing the same
IL177168A0 (en)	2006-12-10	N-sulphonylpyrrole derivatives and pharmaceutical compositions containing the same
IL183986A0 (en)	2007-10-31	Pharmaceutical compounds and compositions
IL197107A0 (en)	2009-11-18	Pharmaceutical compositions including vitamin d and corticosteriod
IL193211A (en)	2013-07-31	Derivatives of Indzol-Troaril and pharmaceutical preparations containing them
IL201730A (en)	2015-09-24	History 1h - Benzaimidazole – 2 – Il – Profile – Methyl – Amino – Ethyl – 5 – Aryl – Bicyclo [2.2.2] Oct – 5 – Ann – 2 – All, Pharmaceutical preparations containing them and their use in the preparation of drugs
EP1890677A4 (fr)	2013-01-30	Compositions pharmaceutiques et leur utilisation
IL186337A0 (en)	2008-01-20	Stannsoporfin compositions and administration
IL178067A0 (en)	2006-12-31	Pharmaceutical dosage forms and compositions

Legal Events

Date	Code	Title	Description
2007-02-23	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2007-03-28	17P	Request for examination filed	Effective date: 20061215
2007-03-28	AK	Designated contracting states	Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR
2007-03-28	AX	Request for extension of the european patent	Extension state: AL BA HR LV MK YU
2007-09-26	DAX	Request for extension of the european patent (deleted)
2008-02-20	A4	Supplementary search report drawn up and despatched	Effective date: 20080123
2008-02-20	RIC1	Information provided on ipc code assigned before grant	Ipc: A61K 38/50 20060101ALI20080117BHEP Ipc: A61K 38/00 20060101ALI20080117BHEP Ipc: A61K 33/24 20060101ALI20080117BHEP Ipc: A61K 33/00 20060101ALI20080117BHEP Ipc: A61P 35/00 20060101ALI20080117BHEP Ipc: A61K 31/513 20060101ALI20080117BHEP Ipc: A61K 31/337 20060101ALI20080117BHEP Ipc: A61K 31/715 20060101AFI20070110BHEP
2009-07-08	17Q	First examination report despatched	Effective date: 20090605
2010-03-05	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2010-04-07	18D	Application deemed to be withdrawn	Effective date: 20090916